Psychopharmacology series (Psychopharmacology)

Publications in this journal

• Article: Abecarnil shows reduced tolerance development and dependence potential in comparison to diazepam: animal studies.

  W Löscher
  Psychopharmacology series 02/1993; 11:96-112.
• Article: Abecarnil: a new beta-carboline anxiolytic preliminary clinical pharmacology.

  T Duka, W Krause, R Dorow, A Rohloff, H Ott, B Voet
  Psychopharmacology series 02/1993; 11:132-47.
• Article: Residual and negative symptoms in treatment with neuroleptics.

  J M Kane
  Psychopharmacology series 02/1993; 10:131-7.
• Article: Power analysis for correlation of plasma level and clinical data.

  J M Davis, Z Wang
  Psychopharmacology series 02/1993; 10:253-64.
• Article: Methods to facilitate early exploratory testing of novel psychopharmacologic agents in humans.

  W Z Potter, R P Irwin
  Psychopharmacology series 02/1993; 10:111-23.
• Article: The third dopamine receptor (D3): new perspectives in therapeutics.

  B Giros, P Sokoloff, M P Martres, L Lannfelt, M Andrieux, R Besançon, C Pilon, M L Bouthenet, E Souil, J C Schwartz
  Psychopharmacology series 02/1993; 10:82-93.
• Article: Analysis of 935 haloperidol concentration measurements obtained during routine drug monitoring of 134 patients.

  M Gex-Fabry, A E Balant-Gorgia, L P Balant
  Psychopharmacology series 02/1993; 10:246-52.
• Article: Brain serotonin subsystem complexity and receptor heterogeneity: therapeutic potential of selective serotonin agonists and antagonists.

  K P Lesch, C S Aulakh, D L Murphy
  Psychopharmacology series 02/1993; 10:52-69.
• Article: Dopaminergic and serotonergic aspects of acute extrapyramidal syndromes.

  D E Casey
  Psychopharmacology series 02/1993; 10:101-10.
• Article: Immunohistochemical mapping of gamma-aminobutyric acid type-A receptor alpha subunits in rat central nervous system.

  J D Turner, G Bodewitz, C L Thompson, F A Stephenson
  Psychopharmacology series 02/1993; 11:29-49.
• Article: Beta-carboline-3-carboxylic acid ethyl ester: a lead for new psychotropic drugs.

  R Schmiechen, D Seidelmann, A Huth
  Psychopharmacology series 02/1993; 11:7-15.
• Article: Disposition of the neuroleptics perphenazine, zuclopenthixol, and haloperidol cosegregates with polymorphic debrisoquine hydroxylation.

  L Bertilsson, M L Dahl, B Ekqvist, A Llerena
  Psychopharmacology series 02/1993; 10:230-7.
• Article: Clinical dosing of neuroleptics.

  R J Baldessarini, B M Cohen, M H Teicher
  Psychopharmacology series 02/1993; 10:138-48.
• Article: Dose-effect and concentration-effect relationships with new antidepressants.

  S H Preskorn
  Psychopharmacology series 02/1993; 10:174-89.
• Article: Serotonin receptor subtypes.

  P R Hartig, N Adham, J Zgombick, M Macchi, H T Kao, L Schechter, T Branchek, R Weinshank
  Psychopharmacology series 02/1993; 10:15-25.
• Article: Behavioral pharmacology of abecarnil in baboons: reduced dependence and abuse potential.

  C A Sannerud, N A Ator, R R Griffiths
  Psychopharmacology series 02/1993; 11:113-20.
• Article: Serotonin receptors and antipsychotic drug action.

  H Y Meltzer
  Psychopharmacology series 02/1993; 10:70-81.
• Article: Abecarnil: a novel anxiolytic with mixed full agonist/partial agonist properties in animal models of anxiety and sedation.

  D N Stephens, L Turski, G H Jones, K G Steppuhn, H H Schneider
  Psychopharmacology series 02/1993; 11:79-95.
• Article: Neuroleptics and diagnostic heterogeneity in relation to drug evaluation.

  F A Wiesel
  Psychopharmacology series 02/1993; 10:124-30.